RNA in Therapeutics: CRISPR in the Clinic.
Molecules and cells, 46(1): 4-9 PMID 36482771 DOI 10.14348/molcells.2022.0163
Abstract
The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances in these areas.